BMBristol-Myers Squibb BMY · NYSE
$59.84 -1.21% (-$0.73)
- Market cap
- $123.8B
- Enterprise value
- $158.2B
- P/E
- 13.3x
- Forward P/E
- 9.0x
- PEG
- -
- P/S
- 2.5x
- P/FCF
- 10.8x
- EV/EBITDA
- 9.5x
- ROIC
- 15.5%
- Bruto marža
- 70.2%
- Neto marža
- 18.9%
- Dividend yield
- 4.16%
- Payout ratio
- 55.5%
- Neto dolg/EBITDA
- 2.1x
- Beta
- 0.23
- Free float
- 99.8%
O podjetju
Bristol-Myers Squibb Company (BMY) is an American pharmaceutical company with a global reach. The company specializes in research, development, and manufacturing of drugs and biological products for the treatment of various diseases. Bristol-Myers Squibb focuses its efforts on the treatment of cancer, cardiovascular diseases, immune disorders, and other serious conditions. The company is known for its innovative medications that bring significant medical benefits to patients. Bristol-Myers Squibb has a wide range of drugs on the market, and its products are distributed worldwide. The company also has an active research program aimed at discovering new drugs and therapeutic approaches. Bristol-Myers Squibb Company (BMY) shares are an attractive choice for investors who follow the pharmaceutical sector and seek investment opportunities in a renowned pharmaceutical company with a focus on innovative treatment methods.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Christopher Boerner
Employees
32,500
Headquarters
Princeton
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke